221 related articles for article (PubMed ID: 35833131)
1. IFNAR1 Deficiency Impairs Immunostimulatory Properties of Neutrophils in Tumor-Draining Lymph Nodes.
Hussain T; Domnich M; Bordbari S; Pylaeva E; Siakaeva E; Spyra I; Ozel I; Droege F; Squire A; Lienenklaus S; Sutter K; Hasenberg A; Gunzer M; Lang S; Jablonska J
Front Immunol; 2022; 13():878959. PubMed ID: 35833131
[TBL] [Abstract][Full Text] [Related]
2. Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytes.
Lu C; Klement JD; Ibrahim ML; Xiao W; Redd PS; Nayak-Kapoor A; Zhou G; Liu K
J Immunother Cancer; 2019 Jun; 7(1):157. PubMed ID: 31228946
[TBL] [Abstract][Full Text] [Related]
3. Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of
Schleicher U; Liese J; Justies N; Mischke T; Haeberlein S; Sebald H; Kalinke U; Weiss S; Bogdan C
Front Immunol; 2018; 9():79. PubMed ID: 29459858
[TBL] [Abstract][Full Text] [Related]
4. Type I IFN signaling triggers immunopathology in tuberculosis-susceptible mice by modulating lung phagocyte dynamics.
Dorhoi A; Yeremeev V; Nouailles G; Weiner J; Jörg S; Heinemann E; Oberbeck-Müller D; Knaul JK; Vogelzang A; Reece ST; Hahnke K; Mollenkopf HJ; Brinkmann V; Kaufmann SH
Eur J Immunol; 2014 Aug; 44(8):2380-93. PubMed ID: 24782112
[TBL] [Abstract][Full Text] [Related]
5. Type I IFN protects cancer cells from CD8+ T cell-mediated cytotoxicity after radiation.
Chen J; Cao Y; Markelc B; Kaeppler J; Vermeer JA; Muschel RJ
J Clin Invest; 2019 Oct; 129(10):4224-4238. PubMed ID: 31483286
[TBL] [Abstract][Full Text] [Related]
6. During early stages of cancer, neutrophils initiate anti-tumor immune responses in tumor-draining lymph nodes.
Pylaeva E; Korschunow G; Spyra I; Bordbari S; Siakaeva E; Ozel I; Domnich M; Squire A; Hasenberg A; Thangavelu K; Hussain T; Goetz M; Lang KS; Gunzer M; Hansen W; Buer J; Bankfalvi A; Lang S; Jablonska J
Cell Rep; 2022 Aug; 40(7):111171. PubMed ID: 35977505
[TBL] [Abstract][Full Text] [Related]
7. IL-17 promotes neutrophil entry into tumor-draining lymph nodes following induction of sterile inflammation.
Brackett CM; Muhitch JB; Evans SS; Gollnick SO
J Immunol; 2013 Oct; 191(8):4348-57. PubMed ID: 24026079
[TBL] [Abstract][Full Text] [Related]
8. Role of type 1 IFNs in antiglioma immunosurveillance--using mouse studies to guide examination of novel prognostic markers in humans.
Fujita M; Scheurer ME; Decker SA; McDonald HA; Kohanbash G; Kastenhuber ER; Kato H; Bondy ML; Ohlfest JR; Okada H
Clin Cancer Res; 2010 Jul; 16(13):3409-19. PubMed ID: 20472682
[TBL] [Abstract][Full Text] [Related]
9. A critical role of STING-triggered tumor-migrating neutrophils for anti-tumor effect of intratumoral cGAMP treatment.
Nagata M; Kosaka A; Yajima Y; Yasuda S; Ohara M; Ohara K; Harabuchi S; Hayashi R; Funakoshi H; Ueda J; Kumai T; Nagato T; Oikawa K; Harabuchi Y; Esteban C; Ohkuri T; Kobayashi H
Cancer Immunol Immunother; 2021 Aug; 70(8):2301-2312. PubMed ID: 33507344
[TBL] [Abstract][Full Text] [Related]
10. Neuronal Ablation of Alpha/Beta Interferon (IFN-α/β) Signaling Exacerbates Central Nervous System Viral Dissemination and Impairs IFN-γ Responsiveness in Microglia/Macrophages.
Hwang M; Bergmann CC
J Virol; 2020 Sep; 94(20):. PubMed ID: 32796063
[TBL] [Abstract][Full Text] [Related]
11. Cancer-specific type-I interferon receptor signaling promotes cancer stemness and effector CD8+ T-cell exhaustion.
Gong W; Donnelly CR; Heath BR; Bellile E; Donnelly LA; Taner HF; Broses L; Brenner JC; Chinn SB; Ji RR; Wen H; Nör JE; Wang J; Wolf GT; Xie Y; Lei YL
Oncoimmunology; 2021; 10(1):1997385. PubMed ID: 34858725
[TBL] [Abstract][Full Text] [Related]
12. Type I interferon signaling regulates Ly6C(hi) monocytes and neutrophils during acute viral pneumonia in mice.
Seo SU; Kwon HJ; Ko HJ; Byun YH; Seong BL; Uematsu S; Akira S; Kweon MN
PLoS Pathog; 2011 Feb; 7(2):e1001304. PubMed ID: 21383977
[TBL] [Abstract][Full Text] [Related]
13. Pathological and immunological characterization of bluetongue virus serotype 1 infection in type I interferons blocked immunocompetent adult mice.
Saminathan M; Singh KP; Maity M; Vineetha S; Manjunathareddy GB; Dhama K; Malik YS; Ramakrishnan MA; Misri J; Gupta VK
J Adv Res; 2021 Jul; 31():137-153. PubMed ID: 34194838
[TBL] [Abstract][Full Text] [Related]
14. Lymphatic Type 1 Interferon Responses Are Critical for Control of Systemic Reovirus Dissemination.
Phillips MB; Dina Zita M; Howells MA; Weinkopff T; Boehme KW
J Virol; 2021 Jan; 95(4):. PubMed ID: 33208448
[TBL] [Abstract][Full Text] [Related]
15. A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses.
Hwang SY; Hertzog PJ; Holland KA; Sumarsono SH; Tymms MJ; Hamilton JA; Whitty G; Bertoncello I; Kola I
Proc Natl Acad Sci U S A; 1995 Nov; 92(24):11284-8. PubMed ID: 7479980
[TBL] [Abstract][Full Text] [Related]
16. Type I interferon signaling enhances CD8+ T cell effector function and differentiation during murine gammaherpesvirus 68 infection.
Jennings RN; Grayson JM; Barton ES
J Virol; 2014 Dec; 88(24):14040-9. PubMed ID: 25253356
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological inhibition of type I interferon signaling protects mice against lethal sepsis.
Dejager L; Vandevyver S; Ballegeer M; Van Wonterghem E; An LL; Riggs J; Kolbeck R; Libert C
J Infect Dis; 2014 Mar; 209(6):960-70. PubMed ID: 24218508
[TBL] [Abstract][Full Text] [Related]
18. Critical role of the endogenous interferon ligand-receptors in type I and type II interferons response.
Lasfar A; Cook JR; Cohen Solal KA; Reuhl K; Kotenko SV; Langer JA; Laskin DL
Immunology; 2014 Jul; 142(3):442-52. PubMed ID: 24597649
[TBL] [Abstract][Full Text] [Related]
19. Adipose type I interferon signalling protects against metabolic dysfunction.
Wieser V; Adolph TE; Grander C; Grabherr F; Enrich B; Moser P; Moschen AR; Kaser S; Tilg H
Gut; 2018 Jan; 67(1):157-165. PubMed ID: 28011892
[TBL] [Abstract][Full Text] [Related]
20. Cellular dynamics in tumour microenvironment along with lung cancer progression underscore spatial and evolutionary heterogeneity of neutrophil.
Peng H; Wu X; Liu S; He M; Tang C; Wen Y; Xie C; Zhong R; Li C; Xiong S; Liu J; Zheng H; He J; Lu X; Liang W
Clin Transl Med; 2023 Jul; 13(7):e1340. PubMed ID: 37491740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
